Citation Impact
Citing Papers
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?
1997
Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection
1999
In vitro antibacterial activity of some plant essential oils
2006 Standout
Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint
2017 Standout
Review on plant antimicrobials: a mechanistic viewpoint
2019 Standout
Antimicrobial activities of Eugenol and Cinnamaldehyde against the human gastric pathogen Helicobacter pylori
2005
13C-urea breath test in the management of Helicobacter pylori infection
2005
Cancer burden in the year 2000. The global picture
2001 Standout
Medicinal plants and antimicrobial activity
2005 Standout
Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials
2016
Enhancing Compliance Not A Prerequisite for Effective Eradication of Helicobacter Pylori : The Help Study
1999
Metronidazole‐resistant Helicobacter pylori in an urban Asian population
2000
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome
2004
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Effect of Proton-Pump Inhibitor Therapy on Diagnostic Testing for Helicobacter pylori
1998
Meta‐analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first‐line therapies for Helicobacter pylori
2007
Rapid eradication of Helicobacter pylori infection
1995
IMMUNOLOGY OF HELICOBACTER PYLORI AND PROSPECTS FOR VACCINE
2000
The threat of antimicrobial resistance in developing countries: causes and control strategies
2017 Standout
Metagenomic biomarker discovery and explanation
2011 Standout
Metronidazole
1997
Eradication ofH. pyloriwith Pantoprazole, Clarithromycin, and Metronidazole in Duodenal Ulcer Patients: A Head‐to‐Head Comparison Between Two Regimens of Different Duration
2000
Antibacterial activity of extracts from some edible plants commonly consumed in Asia
2003 Standout
Host Response and Vaccine Development to Helicobacter pylori Infection
1999
CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy ofHelicobacter pyloriinfection
2009
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
13C‐urea Breath Test during Hospitalization for the Diagnosis of Helicobacter pylori Infection in Peptic Ulcer Bleeding
2007
Effect of Pretreatment Antibiotic Resistance to Metronidazole and Clarithromycin on Outcome of Helicobacter pylori Therapy
2000
Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials
1996
The HOMER Study: The Effect of Increasing the Dose of Metronidazole When Given with Omeprazole and Amoxicillin to Cure Helicobacter pylori Infection
2000
Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro
1996
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Studies Regarding The Mechanism of False Negative Urea Breath Tests With Proton Pump Inhibitors
2003
Management of Patients With Ulcer Bleeding
2012 Standout
Clove (Syzygium aromaticum): a precious spice
2014 Standout
Helicobacter pylori: perspectives and time trends
2014
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Long-term prospective study ofHelicobacter pylori in nonulcer dyspepsia
1995
Helicobacter pyloriReinfection Is Virtually Absent after Successful Eradication
1997
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
Helicobacter pyloriInfection
2002 Standout
Treatment of Helicobacter pylori Infection: A Review of the World Literature
1996
Eradication of Helicobacter pylori by 7‐Day Triple‐Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double‐Blind, Randomized Studies
2003
DNA breakage due to metronidazole treatment
2001
Clinical Relevance of resistant strains of Helicobacter pylori: a review of current data
1998
Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A meta-analysis
2015
Triple Antimicrobial Therapy and Acid Suppression in Dogs with Chronic Vomiting and Gastric Helicobacter spp
2007
Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children
2013
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Interventions to Enhance Patient Adherence to Medication Prescriptions
2002 Standout
Endoscopic, Biopsy, and Histopathologic Guidelines for the Evaluation of Gastrointestinal Inflammation in Companion Animals
2010 Standout
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study
1998
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era
2009
Second‐line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies
2003
Review article: ‘true’ re‐infection of Helicobacter pylori after successful eradication – worldwide annual rates, risk factors and clinical implications
2008
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: a review
2007 Standout
The pros, cons, and many unknowns of probiotics
2019 Standout
Meta‐analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy
2006
Eugenol—From the Remote Maluku Islands to the International Market Place: A Review of a Remarkable and Versatile Molecule
2012 Standout
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Garlic: a review of potential therapeutic effects.
2014 Standout
Clarithromycin Resistance and Eradication of Helicobacter pylori in Children
2001
Eradication ofHelicobacter pylori
1996
Interventions for enhancing medication adherence
2008 Standout
High Levels of Resistance to Metronidazole and Clarithromycin in Helicobacter pylori Strains in Children
2001
Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia
2017 StandoutNobel
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Interventions for enhancing medication adherence
2014 Standout
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
2001 Standout
Molecular biology of microbial ureases
1995 Standout
Activities of Garlic Oil, Garlic Powder, and Their Diallyl Constituents against Helicobacter pylori
2000
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Epidemiology of gastric cancer
2006 Standout
Comparison of PCR-based restriction length polymorphism analysis of urease genes with rRNA gene profiling for monitoring Helicobacter pylori infections in patients on triple therapy
1994
Works of J. E. TROWELL being referenced
Autoimmune oophoritis associated with polycystic ovaries
1991
Short report: omepmzole plus antibiotic combinations for the eradication of metronidazole‐resistant Helicobacter pylori
1992
Omeprazole and Helicobacter Pylori: temporary suppression rather than true eradication
1991
Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination
1990
Experience with‘triple’ anti‐Helicobacter pylori eradication therapy: side effects and the importance of testing the pre‐treatment bacterial isolate for metronidazole resistance
1992
Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications
1994
Reinfection or recrudescence after apparently successful eradication of <italic>Helicobacter pylori</italic> infection: implications for treatment of patients with duodenal ulcer disease
1993
<italic>Helicobacter pylori eradication</italic>: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens
1993